Ownership of a factory, ownership of a patent and authority over the next product version are separate commercial positions. Contracts and technical-access rights determine the practical control behind investment totals.
The Industrial IP Control Test is a method for screening an investment, technology partnership or licensed manufacturing agreement before commitments are irreversible. It does not treat domestic incorporation or a patent count as proof of control.
1. Define the asset and the decision
Begin with the specific technology or product. Identify the legal entity operating it, relevant jurisdictions, which agreements exist and the commercial decision being examined. Rights granted for one product, plant, territory or term must not be assumed to extend to another.
2. Conduct five rights examinations
Control question
Documents or evidence to inspect
Decision significance
Control question
Documents or evidence to inspect
Decision significance
Control question
Documents or evidence to inspect
Decision significance
Control question
Documents or evidence to inspect
Decision significance
Control question
Documents or evidence to inspect
Decision significance
| Control question | Documents or evidence to inspect | Decision significance |
|---|---|---|
| Who defines the product? | Architecture ownership, specification authority, design files, approved changes | Who can determine the next commercial version? |
| Who may manufacture it? | Patents, know-how licences, territorial or field restrictions, sublicensing rights | Can supply continue and expand lawfully? |
| Who can fix and upgrade it? | Source/process access, technical-data rights, toolchain dependencies, derivative-work permissions | Can the enterprise correct faults and respond to new requirements? |
| Who owns commercial returns? | Pricing rights, royalties, exclusivity, customer contracts, licensing income | Where does product value accrue? |
| What survives interruption? | Termination clauses, escrow/access arrangements, export permissions, alternative suppliers | Does the capability remain usable if a counterparty withdraws? |
The evaluator records each answer as documented, conditional, not held or not evidenced. A failure to obtain a confidential contract is not proof that a right is absent. Neither is ownership of a patent proof of freedom to operate where other patents may apply.
3. Record the controlling rights decision
A semiconductor designer may hold circuit-design rights alongside foundry and software dependencies. Those dependencies may be commercially normal if contracts and alternatives preserve its ability to serve customers. A factory assembling products under a restricted technology licence may generate valuable employment and export revenue without controlling product evolution.
The control finding determines the commercial response: renegotiate amendment rights, secure longer support, extend licensed territories, qualify alternative suppliers or explicitly price a bounded dependency. The investment decision then rests on the residual exposure.
4. Worked rights record — illustrative, not a reported contract
Suppose a manufacturer holds a licence to make an existing electronic component for five years in one market but seeks funding to enter export markets and release an upgraded design.
Proposed action
Evidenced right in the hypothetical agreement
Appraisal outcome
Proposed action
Evidenced right in the hypothetical agreement
Appraisal outcome
Proposed action
Evidenced right in the hypothetical agreement
Appraisal outcome
Proposed action
Evidenced right in the hypothetical agreement
Appraisal outcome
| Proposed action | Evidenced right in the hypothetical agreement | Appraisal outcome |
|---|---|---|
| Supply existing domestic customers | Domestic manufacture permitted for five years | Supported during licence term |
| Enter export markets | Territory clause covers only domestic sales | Requires licence expansion |
| Modify the product design | No amendment clause has been provided | Not evidenced; request agreement and technical rights |
| Continue after licence expiry | No extension or transition evidence provided | Continuity exposure remains unresolved |
The example yields separate control findings for separate intended uses of an otherwise viable capital project. It invents no real company's contractual position.
5. Accountability and boundary
The investment committee decides whether the remaining exposure is acceptable; legal advisers establish contractual rights and applicable law; technical teams determine whether the granted access is sufficient to exercise those rights. Regulators and courts retain their legal authority. A public institution may condition its own support on adequate evidence but cannot rewrite third-party licences by fiat.
The method does not value patents numerically, establish legal validity or replace freedom-to-operate advice. It identifies the contract clauses and technical access that a capital decision must not leave implicit.
Source and further reading
Foundations: Own the Architecture, or Rent the Future, Raja Koduri cover story, Issue 5; When Invention Becomes Property, Prof. Unnat Pandit Leader Blueprint, Issue 5; Own The Design. Own The Market., Dr Satya Gupta, Issue 5; The Product Mastery Manifesto: The Product Pivot, Raja Manickam, Issue 2.
Status: Original INDIA FRONT editorial assessment method, not a legal opinion or an adopted investment criterion. Compared with a technology licence's process-transfer rights, this framework examines the wider commercial rights held over a product's life.